Click for best price
Bacteriophage Therapy Market Size, Share 2023
| Market size in 2022 |
US$ 33 million
|
Forecast Market size by 2029 |
US$ 61 million
|
| Growth Rate |
CAGR of 9.2% |
Number of Pages |
113 Pages |
The global Bacteriophage Therapy market was valued at US$ 33 million in 2022 and is projected to reach US$ 61 million by 2029, at a CAGR of 9.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
This report aims to provide a comprehensive presentation of the global market for Bacteriophage Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophage Therapy. This report contains market size and forecasts of Bacteriophage Therapy in global, including the following market information:
- Global Bacteriophage Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global top five companies in 2022 (%)
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
We surveyed the Bacteriophage Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bacteriophage Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Bacteriophage Therapy Market Segment Percentages, by Type, 2022 (%)
Global Bacteriophage Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Bacteriophage Therapy Market Segment Percentages, by Application, 2022 (%)
- Organ Transplantation
- Bacterial Infections
- Alcoholic Hepatitis
- Other
Global Bacteriophage Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Bacteriophage Therapy Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Bacteriophage Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Bacteriophage Therapy revenues share in global market, 2022 (%)
key players include:
- Armata Pharmaceuticals, Inc.
- Eliava Biopreparations Ltd.
- Pherecydes Pharma
- Intralytix, Inc.
- Phagelux Inc.
- Nextbiotics
- InnoPhage, Ltd
- Locus Biosciences, Inc.
- TechnoPhage
- Eligo Bioscience SA
- Phagomed Biopharma GmbH.
- PhagePro, Inc.
- Adaptive Phage Therapeutics, Inc.
- EnBiotix, Inc.
- Intodeworld, Inc.
- BiomX Ltd.
- Phi Therapeutics
- Fixed-phage Ltd.
- Micreos BV
- ContraFect Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bacteriophage Therapy, market overview.
Chapter 2: Global Bacteriophage Therapy market size in revenue.
Chapter 3: Detailed analysis of Bacteriophage Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bacteriophage Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Bacteriophage Therapy Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 33 million
|
| Forecast Market size by 2029 |
US$ 61 million
|
| Growth Rate |
CAGR of 9.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
113 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Bacteriophage Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bacteriophage Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bacteriophage Therapy Overall Market Size
2.1 Global Bacteriophage Therapy Market Size: 2022 VS 2029
2.2 Global Bacteriophage Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bacteriophage Therapy Players in Global Market
3.2 Top Global Bacteriophage Therapy Companies Ranked by Revenue
3.3 Global Bacteriophage Therapy Revenue by Companies
3.4 Top 3 and Top 5 Bacteriophage Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Bacteriophage Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bacteriophage Therapy Players in Global Market
3.6.1 List of Global Tier 1 Bacteriophage Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Bacteriophage Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Bacteriophage Therapy Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Topical
4.1.4 Parenteral
4.2 By Type - Global Bacteriophage Therapy Revenue & Forecasts
4.2.1 By Type - Global Bacteriophage Therapy Revenue, 2018-2023
4.2.2 By Type - Global Bacteriophage Therapy Revenue, 2024-2029
4.2.3 By Type - Global Bacteriophage Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bacteriophage Therapy Market Size, 2022 & 2029
5.1.2 Organ Transplantation
5.1.3 Bacterial Infections
5.1.4 Alcoholic Hepatitis
5.1.5 Other
5.2 By Application - Global Bacteriophage Therapy Revenue & Forecasts
5.2.1 By Application - Global Bacteriophage Therapy Revenue, 2018-2023
5.2.2 By Application - Global Bacteriophage Therapy Revenue, 2024-2029
5.2.3 By Application - Global Bacteriophage Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Bacteriophage Therapy Market Size, 2022 & 2029
6.2 By Region - Global Bacteriophage Therapy Revenue & Forecasts
6.2.1 By Region - Global Bacteriophage Therapy Revenue, 2018-2023
6.2.2 By Region - Global Bacteriophage Therapy Revenue, 2024-2029
6.2.3 By Region - Global Bacteriophage Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Bacteriophage Therapy Revenue, 2018-2029
6.3.2 US Bacteriophage Therapy Market Size, 2018-2029
6.3.3 Canada Bacteriophage Therapy Market Size, 2018-2029
6.3.4 Mexico Bacteriophage Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Bacteriophage Therapy Revenue, 2018-2029
6.4.2 Germany Bacteriophage Therapy Market Size, 2018-2029
6.4.3 France Bacteriophage Therapy Market Size, 2018-2029
6.4.4 U.K. Bacteriophage Therapy Market Size, 2018-2029
6.4.5 Italy Bacteriophage Therapy Market Size, 2018-2029
6.4.6 Russia Bacteriophage Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Bacteriophage Therapy Market Size, 2018-2029
6.4.8 Benelux Bacteriophage Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Bacteriophage Therapy Revenue, 2018-2029
6.5.2 China Bacteriophage Therapy Market Size, 2018-2029
6.5.3 Japan Bacteriophage Therapy Market Size, 2018-2029
6.5.4 South Korea Bacteriophage Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Bacteriophage Therapy Market Size, 2018-2029
6.5.6 India Bacteriophage Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Bacteriophage Therapy Revenue, 2018-2029
6.6.2 Brazil Bacteriophage Therapy Market Size, 2018-2029
6.6.3 Argentina Bacteriophage Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Bacteriophage Therapy Revenue, 2018-2029
6.7.2 Turkey Bacteriophage Therapy Market Size, 2018-2029
6.7.3 Israel Bacteriophage Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Bacteriophage Therapy Market Size, 2018-2029
6.7.5 UAE Bacteriophage Therapy Market Size, 2018-2029
7 Bacteriophage Therapy Companies Profiles
7.1 Armata Pharmaceuticals, Inc.
7.1.1 Armata Pharmaceuticals, Inc. Company Summary
7.1.2 Armata Pharmaceuticals, Inc. Business Overview
7.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Major Product Offerings
7.1.4 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.1.5 Armata Pharmaceuticals, Inc. Key News & Latest Developments
7.2 Eliava Biopreparations Ltd.
7.2.1 Eliava Biopreparations Ltd. Company Summary
7.2.2 Eliava Biopreparations Ltd. Business Overview
7.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Major Product Offerings
7.2.4 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.2.5 Eliava Biopreparations Ltd. Key News & Latest Developments
7.3 Pherecydes Pharma
7.3.1 Pherecydes Pharma Company Summary
7.3.2 Pherecydes Pharma Business Overview
7.3.3 Pherecydes Pharma Bacteriophage Therapy Major Product Offerings
7.3.4 Pherecydes Pharma Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.3.5 Pherecydes Pharma Key News & Latest Developments
7.4 Intralytix, Inc.
7.4.1 Intralytix, Inc. Company Summary
7.4.2 Intralytix, Inc. Business Overview
7.4.3 Intralytix, Inc. Bacteriophage Therapy Major Product Offerings
7.4.4 Intralytix, Inc. Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.4.5 Intralytix, Inc. Key News & Latest Developments
7.5 Phagelux Inc.
7.5.1 Phagelux Inc. Company Summary
7.5.2 Phagelux Inc. Business Overview
7.5.3 Phagelux Inc. Bacteriophage Therapy Major Product Offerings
7.5.4 Phagelux Inc. Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.5.5 Phagelux Inc. Key News & Latest Developments
7.6 Nextbiotics
7.6.1 Nextbiotics Company Summary
7.6.2 Nextbiotics Business Overview
7.6.3 Nextbiotics Bacteriophage Therapy Major Product Offerings
7.6.4 Nextbiotics Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.6.5 Nextbiotics Key News & Latest Developments
7.7 InnoPhage, Ltd
7.7.1 InnoPhage, Ltd Company Summary
7.7.2 InnoPhage, Ltd Business Overview
7.7.3 InnoPhage, Ltd Bacteriophage Therapy Major Product Offerings
7.7.4 InnoPhage, Ltd Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.7.5 InnoPhage, Ltd Key News & Latest Developments
7.8 Locus Biosciences, Inc.
7.8.1 Locus Biosciences, Inc. Company Summary
7.8.2 Locus Biosciences, Inc. Business Overview
7.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Major Product Offerings
7.8.4 Locus Biosciences, Inc. Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.8.5 Locus Biosciences, Inc. Key News & Latest Developments
7.9 TechnoPhage
7.9.1 TechnoPhage Company Summary
7.9.2 TechnoPhage Business Overview
7.9.3 TechnoPhage Bacteriophage Therapy Major Product Offerings
7.9.4 TechnoPhage Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.9.5 TechnoPhage Key News & Latest Developments
7.10 Eligo Bioscience SA
7.10.1 Eligo Bioscience SA Company Summary
7.10.2 Eligo Bioscience SA Business Overview
7.10.3 Eligo Bioscience SA Bacteriophage Therapy Major Product Offerings
7.10.4 Eligo Bioscience SA Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.10.5 Eligo Bioscience SA Key News & Latest Developments
7.11 Phagomed Biopharma GmbH.
7.11.1 Phagomed Biopharma GmbH. Company Summary
7.11.2 Phagomed Biopharma GmbH. Business Overview
7.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Major Product Offerings
7.11.4 Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.11.5 Phagomed Biopharma GmbH. Key News & Latest Developments
7.12 PhagePro, Inc.
7.12.1 PhagePro, Inc. Company Summary
7.12.2 PhagePro, Inc. Business Overview
7.12.3 PhagePro, Inc. Bacteriophage Therapy Major Product Offerings
7.12.4 PhagePro, Inc. Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.12.5 PhagePro, Inc. Key News & Latest Developments
7.13 Adaptive Phage Therapeutics, Inc.
7.13.1 Adaptive Phage Therapeutics, Inc. Company Summary
7.13.2 Adaptive Phage Therapeutics, Inc. Business Overview
7.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Major Product Offerings
7.13.4 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.13.5 Adaptive Phage Therapeutics, Inc. Key News & Latest Developments
7.14 EnBiotix, Inc.
7.14.1 EnBiotix, Inc. Company Summary
7.14.2 EnBiotix, Inc. Business Overview
7.14.3 EnBiotix, Inc. Bacteriophage Therapy Major Product Offerings
7.14.4 EnBiotix, Inc. Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.14.5 EnBiotix, Inc. Key News & Latest Developments
7.15 Intodeworld, Inc.
7.15.1 Intodeworld, Inc. Company Summary
7.15.2 Intodeworld, Inc. Business Overview
7.15.3 Intodeworld, Inc. Bacteriophage Therapy Major Product Offerings
7.15.4 Intodeworld, Inc. Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.15.5 Intodeworld, Inc. Key News & Latest Developments
7.16 BiomX Ltd.
7.16.1 BiomX Ltd. Company Summary
7.16.2 BiomX Ltd. Business Overview
7.16.3 BiomX Ltd. Bacteriophage Therapy Major Product Offerings
7.16.4 BiomX Ltd. Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.16.5 BiomX Ltd. Key News & Latest Developments
7.17 Phi Therapeutics
7.17.1 Phi Therapeutics Company Summary
7.17.2 Phi Therapeutics Business Overview
7.17.3 Phi Therapeutics Bacteriophage Therapy Major Product Offerings
7.17.4 Phi Therapeutics Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.17.5 Phi Therapeutics Key News & Latest Developments
7.18 Fixed-phage Ltd.
7.18.1 Fixed-phage Ltd. Company Summary
7.18.2 Fixed-phage Ltd. Business Overview
7.18.3 Fixed-phage Ltd. Bacteriophage Therapy Major Product Offerings
7.18.4 Fixed-phage Ltd. Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.18.5 Fixed-phage Ltd. Key News & Latest Developments
7.19 Micreos BV
7.19.1 Micreos BV Company Summary
7.19.2 Micreos BV Business Overview
7.19.3 Micreos BV Bacteriophage Therapy Major Product Offerings
7.19.4 Micreos BV Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.19.5 Micreos BV Key News & Latest Developments
7.20 ContraFect Corporation
7.20.1 ContraFect Corporation Company Summary
7.20.2 ContraFect Corporation Business Overview
7.20.3 ContraFect Corporation Bacteriophage Therapy Major Product Offerings
7.20.4 ContraFect Corporation Bacteriophage Therapy Revenue in Global Market (2018-2023)
7.20.5 ContraFect Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Bacteriophage Therapy Market Opportunities & Trends in Global Market
Table 2. Bacteriophage Therapy Market Drivers in Global Market
Table 3. Bacteriophage Therapy Market Restraints in Global Market
Table 4. Key Players of Bacteriophage Therapy in Global Market
Table 5. Top Bacteriophage Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Bacteriophage Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Bacteriophage Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Bacteriophage Therapy Product Type
Table 9. List of Global Tier 1 Bacteriophage Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bacteriophage Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Bacteriophage Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Bacteriophage Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Bacteriophage Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Bacteriophage Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Bacteriophage Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Bacteriophage Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Bacteriophage Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Bacteriophage Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Bacteriophage Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Bacteriophage Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Bacteriophage Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Bacteriophage Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Bacteriophage Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Bacteriophage Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Bacteriophage Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Bacteriophage Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Bacteriophage Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Bacteriophage Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Bacteriophage Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Armata Pharmaceuticals, Inc. Company Summary
Table 31. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Offerings
Table 32. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Armata Pharmaceuticals, Inc. Key News & Latest Developments
Table 34. Eliava Biopreparations Ltd. Company Summary
Table 35. Eliava Biopreparations Ltd. Bacteriophage Therapy Product Offerings
Table 36. Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Eliava Biopreparations Ltd. Key News & Latest Developments
Table 38. Pherecydes Pharma Company Summary
Table 39. Pherecydes Pharma Bacteriophage Therapy Product Offerings
Table 40. Pherecydes Pharma Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Pherecydes Pharma Key News & Latest Developments
Table 42. Intralytix, Inc. Company Summary
Table 43. Intralytix, Inc. Bacteriophage Therapy Product Offerings
Table 44. Intralytix, Inc. Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Intralytix, Inc. Key News & Latest Developments
Table 46. Phagelux Inc. Company Summary
Table 47. Phagelux Inc. Bacteriophage Therapy Product Offerings
Table 48. Phagelux Inc. Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Phagelux Inc. Key News & Latest Developments
Table 50. Nextbiotics Company Summary
Table 51. Nextbiotics Bacteriophage Therapy Product Offerings
Table 52. Nextbiotics Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Nextbiotics Key News & Latest Developments
Table 54. InnoPhage, Ltd Company Summary
Table 55. InnoPhage, Ltd Bacteriophage Therapy Product Offerings
Table 56. InnoPhage, Ltd Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. InnoPhage, Ltd Key News & Latest Developments
Table 58. Locus Biosciences, Inc. Company Summary
Table 59. Locus Biosciences, Inc. Bacteriophage Therapy Product Offerings
Table 60. Locus Biosciences, Inc. Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Locus Biosciences, Inc. Key News & Latest Developments
Table 62. TechnoPhage Company Summary
Table 63. TechnoPhage Bacteriophage Therapy Product Offerings
Table 64. TechnoPhage Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. TechnoPhage Key News & Latest Developments
Table 66. Eligo Bioscience SA Company Summary
Table 67. Eligo Bioscience SA Bacteriophage Therapy Product Offerings
Table 68. Eligo Bioscience SA Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Eligo Bioscience SA Key News & Latest Developments
Table 70. Phagomed Biopharma GmbH. Company Summary
Table 71. Phagomed Biopharma GmbH. Bacteriophage Therapy Product Offerings
Table 72. Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Phagomed Biopharma GmbH. Key News & Latest Developments
Table 74. PhagePro, Inc. Company Summary
Table 75. PhagePro, Inc. Bacteriophage Therapy Product Offerings
Table 76. PhagePro, Inc. Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. PhagePro, Inc. Key News & Latest Developments
Table 78. Adaptive Phage Therapeutics, Inc. Company Summary
Table 79. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Offerings
Table 80. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Adaptive Phage Therapeutics, Inc. Key News & Latest Developments
Table 82. EnBiotix, Inc. Company Summary
Table 83. EnBiotix, Inc. Bacteriophage Therapy Product Offerings
Table 84. EnBiotix, Inc. Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. EnBiotix, Inc. Key News & Latest Developments
Table 86. Intodeworld, Inc. Company Summary
Table 87. Intodeworld, Inc. Bacteriophage Therapy Product Offerings
Table 88. Intodeworld, Inc. Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Intodeworld, Inc. Key News & Latest Developments
Table 90. BiomX Ltd. Company Summary
Table 91. BiomX Ltd. Bacteriophage Therapy Product Offerings
Table 92. BiomX Ltd. Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. BiomX Ltd. Key News & Latest Developments
Table 94. Phi Therapeutics Company Summary
Table 95. Phi Therapeutics Bacteriophage Therapy Product Offerings
Table 96. Phi Therapeutics Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. Phi Therapeutics Key News & Latest Developments
Table 98. Fixed-phage Ltd. Company Summary
Table 99. Fixed-phage Ltd. Bacteriophage Therapy Product Offerings
Table 100. Fixed-phage Ltd. Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 101. Fixed-phage Ltd. Key News & Latest Developments
Table 102. Micreos BV Company Summary
Table 103. Micreos BV Bacteriophage Therapy Product Offerings
Table 104. Micreos BV Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 105. Micreos BV Key News & Latest Developments
Table 106. ContraFect Corporation Company Summary
Table 107. ContraFect Corporation Bacteriophage Therapy Product Offerings
Table 108. ContraFect Corporation Bacteriophage Therapy Revenue (US$, Mn) & (2018-2023)
Table 109. ContraFect Corporation Key News & Latest Developments
List of Figures
Figure 1. Bacteriophage Therapy Segment by Type in 2022
Figure 2. Bacteriophage Therapy Segment by Application in 2022
Figure 3. Global Bacteriophage Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bacteriophage Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Bacteriophage Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bacteriophage Therapy Revenue in 2022
Figure 8. By Type - Global Bacteriophage Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Bacteriophage Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Bacteriophage Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Bacteriophage Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Bacteriophage Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Bacteriophage Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Bacteriophage Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Bacteriophage Therapy Revenue Market Share, 2018-2029
Figure 16. US Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Bacteriophage Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Bacteriophage Therapy Revenue Market Share, 2018-2029
Figure 28. China Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Bacteriophage Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Bacteriophage Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Bacteriophage Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pherecydes Pharma Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Intralytix, Inc. Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Phagelux Inc. Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Nextbiotics Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. InnoPhage, Ltd Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Locus Biosciences, Inc. Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. TechnoPhage Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eligo Bioscience SA Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. PhagePro, Inc. Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. EnBiotix, Inc. Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Intodeworld, Inc. Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. BiomX Ltd. Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Phi Therapeutics Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Fixed-phage Ltd. Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Micreos BV Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. ContraFect Corporation Bacteriophage Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
